Search - tctmd.com

Displaying 441 - 460 of 647

Sort: Relevancy | Date

News Daily News

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

Todd Neale

April 11, 2019

News Daily News

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Yael L. Maxwell

April 09, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

News Daily News

Hands-Only CPR for Out-of-Hospital Cardiac Arrest Gaining Traction, With Good Results

Caitlin E. Cox

April 01, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

News Conference News CRT 2019

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Yael L. Maxwell

March 06, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

News Daily News

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

Caitlin E. Cox

January 24, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

News Conference News WCC 2018

True Resistant Hypertension Is Prevalent Worldwide

Todd Neale

December 07, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Advertisement

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Hands-Only CPR for Out-of-Hospital Cardiac Arrest Gaining Traction, With Good Results

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Top News in Clinical Cardiology: 2018

True Resistant Hypertension Is Prevalent Worldwide

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content